The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The peptide problem: Hype is outrunning the evidence Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks FDA's Overreach on Compounded Peptides